AAAAAA

   
Results: 1-10 |
Results: 10

Authors: VESLEMES M POLYZOS A LATSI P DIMITROULIS J STAMATIADIS D DARDOUFAS C RASIDAKIS A KATSILAMBROS N JORDANOGLOU J
Citation: M. Veslemes et al., OPTIMAL DURATION OF CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - A RANDOMIZED STUDY OF 4 VERSUS 6 CYCLES OF CISPLATIN-ETOPOSIDE, Journal of chemotherapy, 10(2), 1998, pp. 136-140

Authors: POLYZOS A TSAVARIS N VESLEMES M DARDOUFAS K DOSIOS T KOSMAS C
Citation: A. Polyzos et al., CHEMOTHERAPY OF NON-SMALL-CELL LUNG-CANCER - A PROSPECTIVELY RANDOMIZED STUDY OF CISPLATIN-ETOPOSIDE VERSUS CISPLATIN-MITOMYCIN-VINBLASTINE, Journal of chemotherapy, 9(2), 1997, pp. 102-105

Authors: GORGOULIS VG RASSIDAKIS GZ KARAMERIS AM PAPASTAMATIOU H TRIGIDOU R VESLEMES M RASSIDAKIS AN KITTAS C
Citation: Vg. Gorgoulis et al., IMMUNOHISTOCHEMICAL AND MOLECULAR EVALUATION OF THE MDM-2 GENE-PRODUCT IN BRONCHOGENIC-CARCINOMA, Modern pathology, 9(5), 1996, pp. 544-554

Authors: VESLEMES M POLYZOS A LATSI P DIMITROULIS J DIMAKOU K JORDANOGLOU J
Citation: M. Veslemes et al., OUTCOME OF PATIENTS WITH BRAIN METASTASES AFTER COMBINED-MODALITY THERAPY IN SMALL-CELL LUNG-CANCER (SCLC) - A RETROSPECTIVE STUDY, Journal of chemotherapy, 7(5), 1995, pp. 460-462

Authors: VESLEMES M POLYZOS A LATSI P DIMITROULIS J ORPHANIDOU D RASIDAKIS A JORDANOGLOU J
Citation: M. Veslemes et al., 4 VERSUS 6 COURSES CISPLATIN ETOPOSIDE (EP) WITH EARLY CHEST RADIOTHERAPY - A RANDOMIZED STUDY IN SMALL-CELL LUNG-CANCER (SCLC), European journal of cancer, 31A, 1995, pp. 95-95

Authors: POLYZOS A GIANNIKOS L VESLEMES M KALAHANIS N GIANOPOULOS A GIANNAKOPOULOS K CHRISTODOULOU K
Citation: A. Polyzos et al., CISPLATIN (C) PLUS IFOSFAMIDE (I) FOR PATIENTS WITH OVARIAN-CARCINOMA(OC) WITH PRIOR CARBOPLATIN (CBT) PLUS CYCLOPHOSPHAMIDE (CTX) CHEMOTHERAPY, European journal of cancer, 31A, 1995, pp. 524-524

Authors: GORGOULIS V SFIKAKIS PP KARAMERIS A PAPASTAMATIOU H TRIGIDOU R VESLEMES M SPANDIDOS DA SFIKAKIS P JORDANOGLOU J
Citation: V. Gorgoulis et al., MOLECULAR AND IMMUNOHISTOCHEMICAL STUDY OF CLASS-I GROWTH-FACTOR RECEPTORS IN SQUAMOUS-CELL LUNG CARCINOMAS, Pathology research and practice, 191(10), 1995, pp. 973-981

Authors: TATSIS G VESLEMES M HADJISTAVROU C VOTSIOU A JORDANOGLOU J
Citation: G. Tatsis et al., TREATMENT OF LOWER RESPIRATORY-TRACT INFECTIONS WITH AMOXICILLIN-CLAVULANIC ACID IN ADULTS, Journal of international medical research, 21(2), 1993, pp. 98-101

Authors: GORGOULIS V GIATROMANOLAKI A KARAMERIS A TSATSANIS C ANINOS D OZANNE B VESLEMES M JORDANOGLOU J TRIGIDOU R PAPASTAMATIOU H SPANDIDOS DA
Citation: V. Gorgoulis et al., EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN SQUAMOUS-CELL LUNG CARCINOMAS - AN IMMUNOHISTOCHEMICAL AND GENE ANALYSIS IN FORMALIN-FIXED, PARAFFIN-EMBEDDED MATERIAL, Virchows Archiv. A. Pathological anatomy and histology, 423(4), 1993, pp. 295-302

Authors: NIKOLOVA R KOULOURIS N RAPAKOULIAS P DIMOPOULOU J MANIOU C VESLEMES M RASIDAKIS A JORDANOGLOU J
Citation: R. Nikolova et al., ELECTROPHYSIOLOGICAL STUDY OF THE PHRENIC-NERVE FUNCTION IN PATIENTS WITH PRIMARY LUNG-CANCER, The American review of respiratory disease, 147(4), 1993, pp. 330-330
Risultati: 1-10 |